FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      FDA Approves Abbott's Libre Duo Continuous Glucose and Ketone Monitor

      The U.S. Food and Drug Administration has granted approval for Abbott's Libre Duo, a continuous glucose and ketone monitoring device. This innovative product is notable for being the first of its kind in the United States, allowing users to track both glucose and ketone levels continuously over a 10-day period.

      The Libre Duo aims to provide individuals managing diabetes with more comprehensive data regarding their metabolic state. By monitoring both glucose and ketone levels, the device can help users make more informed decisions about their health and treatment plans. Abbott's new monitor is expected to enhance the management of diabetes and improve patient outcomes.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud